Authors:
BARTLETT JA
WASSERMAN SS
HICKS CB
DODGE RT
WEINHOLD KJ
TACKET CO
KETTER N
WITTEK AE
PALKER TJ
HAYNES BF
Citation: Ja. Bartlett et al., SAFETY AND IMMUNOGENICITY OF AN HLA-BASED HIV ENVELOPE POLYVALENT SYNTHETIC PEPTIDE IMMUNOGEN, AIDS, 12(11), 1998, pp. 1291-1300
Citation: Hf. Staats et al., INTRANASAL IMMUNIZATION IS SUPERIOR TO VAGINAL, GASTRIC, OR RECTAL IMMUNIZATION FOR THE INDUCTION OF SYSTEMIC AND MUCOSAL ANTI-HIV ANTIBODY-RESPONSES, AIDS research and human retroviruses, 13(11), 1997, pp. 945-952
Authors:
PORGADOR A
STAATS HF
FAIOLA B
GILBOA E
PALKER TJ
Citation: A. Porgador et al., INTRANASAL IMMUNIZATION WITH CTL EPITOPE PEPTIDES FROM HIV-1 OR OVALBUMIN AND THE MUCOSAL ADJUVANT CHOLERA-TOXIN INDUCES PEPTIDE-SPECIFIC CTLS AND PROTECTION AGAINST TUMOR-DEVELOPMENT IN-VIVO, The Journal of immunology, 158(2), 1997, pp. 834-841
Citation: Tj. Palker et al., CHARACTERIZATION OF AN ANTIGEN SHARED BY HUMAN THYMIC EPITHELIUM AND HUMAN T-CELL LEUKEMIA-VIRUS P19 GAG PROTEIN, Journal of acquired immune deficiency syndromes and human retrovirology, 11(1), 1996, pp. 10-19
Authors:
STAATS HF
PORGADOR A
FAIOLA B
GILBOA E
PALKER TJ
Citation: Hf. Staats et al., INDUCTION OF CYTOTOXIC T-LYMPHOCYTES (CTL) SPECIFIC FOR HIV-1 OR PROTECTION AGAINST TUMOR CHALLENGE BY INTRANASAL IMMUNIZATION WITH CTL PEPTIDE AND CHOLERA-TOXIN, The FASEB journal, 10(6), 1996, pp. 1105-1105
Citation: Hf. Staats et al., MUCOSAL IMMUNITY TO HIV-1 - SYSTEMIC AND VAGINAL ANTIBODY-RESPONSES AFTER INTRANASAL IMMUNIZATION WITH THE HIV-1 C4 V3 PEPTIDE T1SP10 MN(A)/, The Journal of immunology, 157(1), 1996, pp. 462-472
Citation: Hf. Staats et Tj. Palker, INCREASED IMMUNOGENICITY OF PEPTIDES USED AS ORAL VACCINES BY COADMINISTRATION OF PROTEASE INHIBITORS, The FASEB journal, 9(3), 1995, pp. 290-290
Authors:
HOXIE JA
AHUJA M
HAGGARTY BS
PALKER TJ
MONTEFIORE DC
Citation: Ja. Hoxie et al., PRODUCTION OF POTENT NEUTRALIZING AND FUSION-INHIBITING MONOCLONAL-ANTIBODIES TO SIVMAC, Journal of cellular biochemistry, 1995, pp. 221-221
Citation: Ns. Horowitz et al., EFFECT OF BISMUTH SALTS ON SYSTEMIC AND MUCOSAL IMMUNE-RESPONSES TO ORALLY-ADMINISTERED CHOLERA-TOXIN, Immunopharmacology, 31(1), 1995, pp. 31-41
Citation: Jm. Winchell et al., PRODUCTION OF IMMUNOGENS TO ELICIT AN ANTI-HIV MUCOSAL IMMUNE-RESPONSE, The FASEB journal, 8(5), 1994, pp. 10000961-10000961
Authors:
DEKABAN GA
KING EE
ARP J
PALKER TJ
RICE GPA
Citation: Ga. Dekaban et al., COMPARATIVE-ANALYSIS OF THE ANTIBODY-RESPONSE TO THE HTLV-I GAG AND ENV PROTEINS IN HTLV-I ASYMPTOMATIC CARRIERS AND HAM TSP PATIENTS - AN ISOTYPE AND SUBCLASS ANALYSIS/, Scandinavian journal of immunology, 40(2), 1994, pp. 171-180
Authors:
WIKTOR SZ
PATE EJ
MURPHY EL
PALKER TJ
CHAMPEGNIE E
RAMLAL A
CRANSTON B
HANCHARD B
BLATTNER WA
Citation: Sz. Wiktor et al., MOTHER-TO-CHILD TRANSMISSION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) IN JAMAICA - ASSOCIATION WITH ANTIBODIES TO ENVELOPE GLYCOPROTEIN (GP46) EPITOPES, Journal of acquired immune deficiency syndromes, 6(10), 1993, pp. 1162-1167
Authors:
HAYNES BF
TORRES JV
LANGLOIS AJ
BOLOGNESI DP
GARDNER MB
PALKER TJ
SCEARCE RM
JONES DM
MOODY MA
MCDANAL C
MATTHEWS TJ
Citation: Bf. Haynes et al., INDUCTION OF BROADLY CROSS-REACTIVE HIV NEUTRALIZING ANTIBODIES IN PRIMATES USING A PRIME-BOOST REGIMEN OF HYBRID SYNTHETIC GP120 ENVELOPE PEPTIDES, AIDS research and human retroviruses, 9, 1993, pp. 190000029-190000029
Citation: Jt. Kimata et al., THE MITOGENIC ACTIVITY OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I IS T-CELL ASSOCIATED AND REQUIRES THE CD2 LFA-3 ACTIVATION PATHWAY/, Journal of virology, 67(6), 1993, pp. 3134-3141
Citation: Y. Yasutomi et al., SYNTHETIC PEPTIDE IN MINERAL-OIL ADJUVANT ELICITS SIMIAN IMMUNODEFICIENCY VIRUS-SPECIFIC CD8-LYMPHOCYTES IN RHESUS-MONKEYS( CYTOTOXIC T), The Journal of immunology, 151(9), 1993, pp. 5096-5105
Authors:
HAYNES BF
TORRES JV
LANGLOIS AJ
BOLOGNESI DP
GARDNER MB
PALKER TJ
SCEARCE RM
JONES DM
MOODY MA
MCDANAL C
MATTHEWS TJ
Citation: Bf. Haynes et al., INDUCTION OF HIVMN NEUTRALIZING ANTIBODIES IN PRIMATES USING A PRIME-BOOST REGIMEN OF HYBRID SYNTHETIC GP120 ENVELOPE PEPTIDES, The Journal of immunology, 151(3), 1993, pp. 1646-1653